Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000649934 | SCV000771770 | likely benign | Charcot-Marie-Tooth disease axonal type 2P | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172644 | SCV001335707 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000649934 | SCV002047853 | likely benign | Charcot-Marie-Tooth disease axonal type 2P | 2021-02-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002424515 | SCV002729177 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV002469233 | SCV002765758 | likely benign | not provided | 2019-12-19 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Prevention |
RCV003965382 | SCV004785748 | likely benign | LRSAM1-related condition | 2023-07-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |